Can a Quantum Support Vector Machine algorithm be utilized to identify Key Biomarkers from Multi-Omics data of COVID19 patients?

The unprecedented global COVID - 19 pandemic has prompted researchers to investigate both the biochemical changes associated with acute infection and the long - term effects of COVID - 19, with the goal of elucidating underlying mechanisms [ 1 4 ]. Among the diverse biochemical alterations observed in COVID - 19, change s in metabolomic and proteomic profiles have drawn particular attention due to their roles in fundamental biological processes, including protein expression and metabolic pathways [5, 6]. Early in the pandemic, several studies highlighted the significance of certain biomarkers for diagnosing COVID - 19 and assessing disease severity [7, 8]. These initial finding s reveal ed that specific biomarkers are involved in COVID - 19 pathogenesis and correlate with disease severity. S ubsequent research into post - acute sequelae of COVID - 19 (PASC, or long COVID) has further shown that variations in these biomarkers are associated with neurological and respiratory complications [9, 10]. Collectively, these studie s highlight the importance of identifying key biomarkers to support both acute COVID - 19 detection and the understanding of long COVID.